Page 9 - Sanket Koul

Madhya Pradesh, Rajasthan probe child deaths linked to cough syrup

Drug authorities in Madhya Pradesh and Rajasthan are probing child deaths linked to cough syrup supplied to government hospitals, with testing of samples and quality concerns

Govt invites proposals under PRIP scheme for pharma, medtech projects

DoP recently notified revised guidelines to make scheme better suited for stakeholders

Leverage Edu targets 2x FY26 revenue on Africa, SE Asia expansion

Leverage Edu is expanding into Africa and Southeast Asia to double FY26 revenue, as Indian students shift away from the US amid visa curbs and new education hubs emerge

Cabinet clears 57 new Kendriya Vidyalayas, 86k students to benefit

The Union Cabinet has approved 57 new Kendriya Vidyalayas with Balvatikas under NEP 2020, with Rs 5,862 crore funding over nine years and focus on underserved districts

Weight-loss drug Ozempic receives CDSCO approval for India launch

Experts say Ozempic's entry is expected to give a boost to the antiobesity market, estimated to be ₹752 crore. Of this market, semaglutide accounts for ₹426 crore

Indian students to gain wider access to education in UK in coming years

With visa curbs in the US, British Council Country Director says students could get dual, joint degrees and credit transfer pathways to improve access

Lupin to acquire VISUfarma BV for €190 mn to expand European eyecare reach

Lupin's unit Nanomi BV will acquire VISUfarma BV from GHO Capital for €190 mn, adding an eyecare portfolio across Europe and strengthening its ophthalmology franchise

Delhi diagnostic players oppose genetic sample outflow ban order

Move was put in place after Delhi saw a fall in sex ratio at birth for 4th straight year, with officials fearing a return of prenatal gender testing

India's pharma exports unlikely to be affected amid Tylenol debate: Experts

Data shows India's paracetamol exports to the US are modest, accounting for less than one per cent of API shipments, despite global attention on the Tylenol controversy

NPPA extends knee implant price ceiling till November 2025 amid review

The NPPA has extended the ceiling price for knee implants till November 2025 while considering industry pleas for removal, citing rising costs and supply chain issues

Polymed acquires 100% stake in Italy-based device maker Citieffe

Poly Medicure will acquire Italy's Citieffe Group for Rs 324 crore, gaining entry into the global orthopaedics market and expanding its overseas footprint after PendraCare

Indian drugmakers gear up for ₹600-800 cr insulin pen market post-Novo exit

Novo Nordisk to phase out insulin pens and cartridges in India; Eris, Wockhardt and Lupin prepare to capture Rs 600-800 crore market opportunity from FY26 onwards

Union Cabinet clears schemes to add 10,000 medical seats by 2028-29

The Union Cabinet has approved Rs 15,034 crore schemes to add 10,000 undergraduate and postgraduate medical seats by 2028-29 through upgradation of government colleges

ONE Group launches The Clermont in Mohali, targets ₹400 cr revenue

ONE Group Developers launches The Clermont in Mohali with 216 units, projected revenue of ₹400 crore and modern aluminium formwork technology for quality and timely delivery

Education ministry launches Viksit Bharat Buildathon for school ideas

The Education Ministry and Atal Innovation Mission launched Viksit Bharat Buildathon to mobilise over one crore students from 1.5 lakh schools for innovation and problem-solving

USFDA cautions doctors on acetaminophen use in pregnancy, cites risks

The US drug regulator flagged concerns over acetaminophen use in pregnancy, citing studies linking it to autism and ADHD, while noting no proven causal relationship

Developers eye festival season demand, GST cuts to revive housing sales

Real estate developers expect GST cuts on inputs and festive buying sentiment to spur housing demand across luxury, mid-segment and Tier-2 cities after a lull in sales

Rise in H-1B fee likely to hit OPT plan of Indian students: Experts

If H-1B visas become harder to secure, the OPT period risks being viewed as a temporary stopgap rather than a pathway to stable employment

Brokers' body resolves differences with MagicBricks after disrespect row

In May this year, NAR India had directed its members to cease all listings, advertisements, and business transactions with MagicBricks and avoid all engagement with the platform

India leads global flex office market, to cross 100 mn sq ft by 2026: C&W

India has topped the global flex office maturity index, with Cushman and Wakefield projecting stock to cross 100 mn sq ft by 2026 on strong demand and operator expansion